Hydromorphone
هیدرومورفون
🧠 Nervous SystemOpioid agonist
Market / country: 🇺🇸 USA
Dilaudid (US)
🧮 Dose calculator
Severe pain requiring an opioid · Regimen source: FDA Hydromorphone tab · 2.3
- • Lowest effective dose for the shortest time. “Every 4–6 h as needed”; the calculator shows 6-hourly. Hepatic or renal impairment: start at one-quarter to one-half the dose. FDA Hydromorphone tab · 2.1FDA Hydromorphone tab · 2.4FDA Hydromorphone tab · 2.5
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Significant respiratory depression; acute or severe asthma without monitoring; GI obstruction or paralytic ileus; hypersensitivity. FDA Hydromorphone tab · 4
Warnings
- • Boxed warning: addiction and misuse, life-threatening respiratory depression, accidental ingestion in children, neonatal opioid withdrawal, interactions with benzodiazepines and CYP3A4 inhibitors. Keep naloxone available. FDA Hydromorphone tab · Boxed WarningFDA Hydromorphone tab · 2.2
Renal adjustment
- • eGFR < 60: Start at one-quarter to one-half the usual dose depending on the degree of impairment. FDA Hydromorphone tab · 2.5
Formulations
- 2 mg tablet — tablet 🇺🇸 USA FDA Hydromorphone tab · 3
- 4 mg tablet — tablet 🇺🇸 USA FDA Hydromorphone tab · 3
- 8 mg tablet (scored) — tablet 🇺🇸 USA FDA Hydromorphone tab · 3
👥 Special populations
- 🤰 PregnancyDangerous / avoid
Label: can cause fetal harm. Dangerous in pregnancy. FDA Hydromorphone tab · Boxed Warning
“Neonatal Opioid Withdrawal Syndrome (NOWS) Advise pregnant women using opioids for an extended period of time of the risk of Neonatal Opioid Withdrawal Syndrome, which may be life-threatening if not recognized and treated.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Hydromorphone tab · 8.2
“Risk Summary Low levels of opioid analgesics have been detected in human milk.”
- 👶 ChildrenSafety not established
Label: not established in children. Accidental ingestion of even one dose by a child can be fatal. FDA Hydromorphone tab · 8.4
“The safety and effectiveness of hydromorphone hydrochloride tablets in pediatric patients have not been established.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Hydromorphone tab · 8.5
“In general, use caution when selecting a dosage for an elderly patient, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function and of concomitant disease or other drug therapy.”
- ⚥ Females & males of reproductive potentialUse with caution
Label has advice on pregnancy testing, contraception or fertility for females and males. FDA Hydromorphone tab · 8.3
“Infertility Use of opioids for an extended period of time may cause reduced fertility in females and males of reproductive potential.”
🔗 Reference links
- FDA (approval record)ANDA076855
- DailyMed (FDA label)FDA Hydromorphone tab
- MedlinePlus (NIH)HydromorphoneHydromorphone Injection
- WHO ATC/DDDN02AA03
- Darooyab (Iran)Hydromorphone
🇮🇷 Not found in Iran list Darooyab · G-100/Hydromorphone
Darooyab lists no registered dosage form or brand for this drug. This does not prove it is unavailable.
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Hydromorphone tab · 3FDA Hydromorphone tab · 2.3FDA Hydromorphone tab · 2.1FDA Hydromorphone tab · 2.4FDA Hydromorphone tab · 2.5FDA Hydromorphone tab · 4FDA Hydromorphone tab · Boxed WarningFDA Hydromorphone tab · 2.2FDA Hydromorphone tab · 8.2FDA Hydromorphone tab · 8.4FDA Hydromorphone tab · 8.5FDA Hydromorphone tab · 8.3FDA Hydromorphone tab · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-100/Hydromorphone
- Clinical review⚠ Unverified